文献速递牙体牙髓病儿童口腔

含CAPE氟化牙膏的龋齿控制:体外、体内与原位分析

Caries Control by CAPE Toothpaste: In Vitro, In Vivo, and In Situ Analysis.
PubMed 文献 · J Dent Res · 2025-10-18

研究研发含咖啡酸苯乙酯(CAPE)的氟化牙膏,通过体外抑菌、大鼠龋齿模型和7天原位临床试验评估其控龋效果。结果显示CAPE牙膏可抑制变形链球菌、降低大鼠龋损评分、促进釉质显微硬度恢复并调节菌群,但需更广泛长期临床验证。

要点

  • CAPE与氟化物联用对变形链球菌呈相加抗菌作用(FIC指数0.75)。
  • 大鼠模型中CAPE牙膏的平滑面龋评分最低(21.0±1.7),沟裂病变较轻。
  • 原位试验中CAPE牙膏使釉质表面显微硬度恢复27.58%。

核心结论

  • 含CAPE的氟化牙膏在体外、大鼠模型和原位临床试验中均显示出控制龋齿发生发展的效果。
  • 仍需更广泛和长期的临床研究验证其疗效。

研究设计与样本

  • 体外采用定量悬浮和棋盘微量稀释法检测对变形链球菌的抗菌活性。
  • 体内使用大鼠龋齿模型,每组9只,比较5组:未处理对照、无CAPE基质牙膏(600 ppm F-)、CAPE氟化牙膏(0.16 mg/mL CAPE+600 ppm F-)、氟化物对照(DARLIE®,600 ppm F-)和蜂胶无氟对照(Red Seal®)。
  • 原位开展7天临床研究(ChiCTR2400089643),评估24块釉质块的修复和6份菌斑样本的微生物组调节,设4组(NC、C、F、P)。

主要发现

  • CAPE牙膏在3分钟内使变形链球菌减少1.5-log10(P=0.0062 vs NC)。
  • 大鼠模型中CAPE牙膏组平滑面龋评分最低(21.0±1.7,P<0.005 vs 所有组),并减轻沟裂病变严重程度(轻度牙本质病变:P=0.0181 vs NC,P=0.0318 vs F)。
  • 原位试验中CAPE牙膏组釉质表面显微硬度恢复27.58%(P<0.01 vs 所有组),矿物丢失和病变深度显著减少(P<0.001 vs 所有组)。
  • 微生物组分析显示CAPE牙膏组保持微生物多样性,增加Streptococcus oralis,减少致龋菌群。

关键数值与推荐

  • CAPE与氟化物联用的FIC指数为0.75,表现为相加抗菌作用。
  • 大鼠平滑面龋评分:CAPE牙膏组21.0±1.7(P<0.005 vs 所有组)。
  • 原位釉质表面显微硬度恢复:CAPE牙膏组27.58%(P<0.01 vs 所有组)。

临床怎么用

  • 含CAPE的氟化牙膏可能作为增强氟化物防龋效果的新型口腔护理产品。
  • 其抗菌和再矿化作用提示可用于龋病高风险人群的日常预防。

局限性

  • 需要更广泛和 longer-term 的临床研究来确认疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Dental caries is closely associated with microbiome dysbiosis. Incorporating antimicrobial agents can enhance the efficacy of fluoride toothpaste. Our previous studies showed that caffeic acid phenethyl ester (CAPE), derived from propolis, effectively inhibited cariogenic bacteria. To formulate a novel CAPE-containing fluoridated toothpaste and establish a multistage evaluation system assessing its caries-controlling efficacy. The CAPE toothpaste's physicochemical properties were characterized. Its in vitro antimicrobial activity against Streptococcus mutans was examined using quantitative suspension and checkerboard microdilution assays. In vivo anticaries efficacy and biosafety were evaluated in a rat caries model (n = 9/group) comparing 5 groups: untreated control (group NC), base toothpaste without CAPE (group B, 600 ppm F-), CAPE-fluoride toothpaste (group C, 0.16 mg/mL CAPE + 600 ppm F-), fluoride control (group F, DARLIE®, 600 ppm F-), and propolis nonfluoride control (group P, Red Seal®). Caries severity was scored using the Keyes method. Finally, in situ enamel repair (n = 24 enamel blocks) and plaque microbiome modulation (n = 6 samples) were assessed in a 7-d clinical study (ChiCTR2400089643) with 4 groups (groups NC, C, F, and P). The novel formulation showed stable physicochemical properties. Group C reduced S. mutans by 1.5-log10 within 3 min (P = 0.0062 vs NC), and CAPE plus fluoride exhibited additive antibacterial properties (fractional inhibitory concentration index = 0.75). In rats, group C showed the lowest smooth-surface score (21.0 ± 1.7, P < 0.005 vs. all) and reduced sulcal lesion severity (slight dentinal lesions: P = 0.0181 vs. NC and P = 0.0318 vs. F). In situ, group C achieved 27.58% surface microhardness recovery (P < 0.01 vs. all), with significant reductions in mineral loss and lesion depth (P < 0.001 vs. all). Microbiome analysis revealed a preserved microbial diversity, increased Streptococcus oralis, and reduced cariogenic populations. The novel CAPE-containing fluoridated toothpaste effectively inhibited the onset and development of caries. Wider-ranging and longer-term clinical investigations are still needed.

来源:J Dent Res,查看原文。版权归原作者所有。

引用

  1. Wang YF, Dong SS, Chen Y, et al. Caries Control by CAPE Toothpaste: In Vitro, In Vivo, and In Situ Analysis. J Dent Res. 2025. PMID: 41108133. doi:10.1177/00220345251374959

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。